Lovely to see you back...
You do realise that 100% growth figure you cite is what is expected for FY24, not FY23 (given FY23 only accounts for 3months of iTrack Advance sales)
No one thought there would be much growth in FY23 given the very recent FDA clearance of iTrack Advance, so the 18% figure is in line with expectations. Europe sales aren't great, but if USA and China performance is maintained that'll carry the FY24 result just fine
Ann: Investor Presentation 30 June 2023 Results, page-6
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.10M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 21.0¢ | $39.39K | 187.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 38328 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 57167 | 2 |
View Market Depth
| Last trade - 15.54pm 29/08/2024 (20 minute delay) ? |
| EYE (ASX) Chart |